Synexa Life Sciences Revenue and Competitors

Leiden,

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • Synexa Life Sciences's estimated annual revenue is currently $25.4M per year.(i)
  • Synexa Life Sciences's estimated revenue per employee is $154,000

Employee Data

  • Synexa Life Sciences has 165 Employees.(i)
  • Synexa Life Sciences grew their employee count by -1% last year.

Synexa Life Sciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEO and co ownerReveal Email/Phone
3
Head Scientific StrategiesReveal Email/Phone
4
Head Financial AccountingReveal Email/Phone
5
Head Quality ManagementReveal Email/Phone
6
Head Study Delivery, USAReveal Email/Phone
7
Head Specimen ManagmentReveal Email/Phone
8
Head Global Career & Skills DevelopmentReveal Email/Phone
9
Head Operations -MEAReveal Email/Phone
10
Head Human ResourcesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M90-36%$14.1MN/A
#2
$83.2M468-3%$251MN/A
#3
$14M1001%N/AN/A
#4
$14.6M0N/A$12.5MN/A
#5
$30.3M197-6%N/AN/A
#6
$0.1M6-25%$2.6MN/A
#7
$45.1M2932%N/AN/A
#8
$4.8M43-7%N/AN/A
#9
$399.3M203740%N/AN/A
#10
$44M2864%N/AN/A
Add Company

What Is Synexa Life Sciences?

Synexa offers deep expertise in biomarker selection and panel design for each phase of clinical development. Our biomarker programs are tailor-made to clients' needs, usually involving considerable up-front scientific collaboration. Our culture is research-based with scientists involved in all lab activities and analysis. This approach is critical to solving challenging problems in new assay development and to the identification of new insights into the clinical pharmacology of the drug. We help clients interpret the results of the biomarker analysis, often in light of the clinical data, to advise on implications for the drug in question.

keywords:N/A

N/A

Total Funding

165

Number of Employees

$25.4M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Synexa Life Sciences News

2022-03-22 - Oncimmune go-to-market partnership with Synexa Life ...

Following an assessment of ImmunoINSIGHT's competence and capability, Synexa Life Sciences has selected Oncimmune's ImmunoINSIGHTS platform...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M1966%N/A
#2
$31.9M200-14%N/A
#3
$44.6M2256%N/A
#4
$89.1M31444%N/A
#5
$51.6M4057%N/A